229 related articles for article (PubMed ID: 18064307)
1. The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis.
Freire de Carvalho J; Sherer Y; Shoenfeld Y
Thromb Haemost; 2007 Dec; 98(6):1157-9. PubMed ID: 18064307
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
3. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
[TBL] [Abstract][Full Text] [Related]
4. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
[TBL] [Abstract][Full Text] [Related]
6. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
7. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
8. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
Frostegård J
Clin Immunol; 2010 Jan; 134(1):47-54. PubMed ID: 19748321
[TBL] [Abstract][Full Text] [Related]
9. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
[TBL] [Abstract][Full Text] [Related]
10. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
Lopez LR; Hurley BL; Simpson DF; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
Hulthe J
Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and atherosclerosis.
Matsuura E; Kobayashi K; Inoue K; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):311-9. PubMed ID: 16391407
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies against low density oxidized lipoproteins in type 2 diabetics].
Malícková K; Skrha J; Janatková I; Vanková Z; Fucíková T
Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272
[TBL] [Abstract][Full Text] [Related]
20. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]